These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 24726630)

  • 21. Fractures in chronic kidney disease: pursuing the best screening and management.
    Goldenstein PT; Jamal SA; Moysés RM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):317-23. PubMed ID: 26050117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Osteoporosis treatment for patients with chronic kidney disease].
    Konishi Y
    Nihon Rinsho; 2015 Oct; 73(10):1723-7. PubMed ID: 26529937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations for mineral and bone disorder in chronic kidney disease].
    Staszków M; Przedlacki J
    Wiad Lek; 2014; 67(3):422-5. PubMed ID: 25782204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy for patients with CKD and low bone mineral density.
    Ott SM
    Nat Rev Nephrol; 2013 Nov; 9(11):681-92. PubMed ID: 24100401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].
    Polak-Jonkisz D; Zwolińska D; Nahaczewska W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):25-8. PubMed ID: 20529602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fracture risk and treatment in chronic kidney disease.
    Connelly K; Collister D; Tangri N
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):221-225. PubMed ID: 29547405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.
    Hampson G; Elder GJ; Cohen-Solal M; Abrahamsen B
    Endocrine; 2021 Sep; 73(3):509-529. PubMed ID: 33974225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Osteoporosis in patients with chronic renal failure : evaluation and management ? Role of bone biopsy].
    Chatzipetrou V; Gerbaix M; Ferrari S; Trombetti A
    Rev Med Suisse; 2018 Nov; 14(626):2012-2017. PubMed ID: 30422421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.
    Evenepoel P; Cunningham J; Ferrari S; Haarhaus M; Javaid MK; Lafage-Proust MH; Prieto-Alhambra D; Torres PU; Cannata-Andia J; ; ;
    Osteoporos Int; 2021 Dec; 32(12):2397-2405. PubMed ID: 34129059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uremic Toxicity and Bone in CKD.
    Yamamoto S; Fukagawa M
    J Nephrol; 2017 Oct; 30(5):623-627. PubMed ID: 28573386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations.
    Bover J; Ureña-Torres P; Torregrosa JV; Rodríguez-García M; Castro-Alonso C; Górriz JL; Laiz Alonso AM; Cigarrán S; Benito S; López-Báez V; Lloret Cora MJ; daSilva I; Cannata-Andía J
    Nefrologia (Engl Ed); 2018; 38(5):476-490. PubMed ID: 29703451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorder.
    Costa AG; Bilezikian JP; Lewiecki EM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):324-9. PubMed ID: 26050118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D.
    Evenepoel P; Cunningham J; Ferrari S; Haarhaus M; Javaid MK; Lafage-Proust MH; Prieto-Alhambra D; Torres PU; Cannata-Andia J;
    Nephrol Dial Transplant; 2021 Jan; 36(1):42-59. PubMed ID: 33098421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production.
    Liao HW; Huang TH; Chang YH; Liou HH; Chou YH; Sue YM; Hung PH; Chang YT; Ho PC; Tsai KJ
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Updates on Lifestyle-Related Diseases and Bone Metabolism. CKD-related osteoporosis].
    Yamada S; Inaba M
    Clin Calcium; 2014 Nov; 24(11):1605-13. PubMed ID: 25355144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care.
    Bover J; Gómez-Alonso C; Casado E; Rodríguez-García M; Lloret MJ; Castro-Alonso C; Gifre L; Henríquez-Palop F; Prior-Español Á; López de la Manzanara V; Láiz AM; Martínez-Ferrer À; Torregrosa JV; Cigarrán S; Górriz JL; Montomoli M; Panizo N; Costa E; Martínez-Laguna D; Rodríguez M; Navarro-González JF
    Nefrologia (Engl Ed); 2024; 44(2):241-250. PubMed ID: 38531765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fragility fracture in the Chronic Kidney Disease (CKD)].
    Fusaro M; Aghi A; Mereu MC; Giusti A
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease-mineral and bone disorder KDIGO guidelines.
    Khwaja A
    Nephron Clin Pract; 2010; 116(1):c25-6. PubMed ID: 20460936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.